The online home for the primary care professionals managing patients with cardiovascular disease, diabetes and related diseases.

Evidence in Practice

Monday, 19 March 2018
A fascinating new study from Sweden and Finland suggests that diabetes is actually five separate diseases and treatment could be tailored for each type. Study authors suggest these findings will usher in a new era of personalised medicine for diabetes.
Topics covered:
Tuesday, 27 February 2018
Chris Arden, Editor-in-chief of the Primary Care Cardiovascular Journal With New Year fading into the distance and the days getting longer, our attention focuses on what this year will bring in cardiovascular disease and diabetes.
Tuesday, 27 February 2018
The prevalence of previously undetected dysglycaemia is high in patients who are free from cardiovascular disease but have one or two other risk factors (hypertension and/or dyslipidaemia). A new study shows that using the FINDRISC questionnaire as a first step of dysglycaemia screening does not provide any benefit in this population.
Topics covered:
Tuesday, 27 February 2018
A recent study using data from the UK Paediatric Familial Hypercholesterolaemia Register shows that statin therapy reduces LDL cholesterol by 31% with no associated liver or muscle damage. Statin use in children is not associated with any reductions in growth rate and is safe in childhood, with no biochemical evidence of toxicity over a 2- to 3-year period.
Friday, 23 February 2018
Stories in this Evidence in Practice include: Health survey for England, 2016: The good and the bad news Healthy lifestyle changes have a long-term benefit for type 2 diabetes prevention Weight loss diets reduce the risk of premature death for people with obesity Very low calorie diet can achieve a remission of Type 2 Diabetes Dash diet plus sodium reduction lowers systolic blood pressure Long-term follow-up underscores benefits of lowering LDL-C in CVD primary prevention Blood pressure self-monitoring is more effective with professional support AF and other chronic conditions = higher risk of death Clinical trials underestimate the real-world impact of Atherosclerotic CVD The burden of heart failure continues to rise in the UK
Tuesday, 23 January 2018
A review of guidelines on the use of statins for primary prevention suggest that US, Canadian and UK guidelines, which recommend lower thresholds for people to receive statins, are more effective than European recommendations.
Tuesday, 23 January 2018
The European Association for the Study of Obesity (EASO) has recently published new guidelines on bariatric surgery and ongoing management, with recommendations for an increased role for primary care in follow-up.
Topics covered:
Tuesday, 23 January 2018
Erectile dysfunction (ED) is an important marker of subclinical cardiovascular disease, according to a new study from the US. A systematic review and meta-analysis of 28 studies, was designed to assess whether ED could be a simple and effective CV disease risk stratification tool.

Article search and filter